Bringing the fundamentals into focus…
Back to Adaptive Biotechnologies Corporation
How Adaptive Biotechnologies Corporation stacks up
ADPT · against 233 other Healthcare companies of similar size
Growth
83/ 100
Near the top of its peers.
Ranked #47 of 234 · scores higher than 79% of peers
Bars: peers in each 10-point band of the growth score28 peers with a growth score of 80–89, including ADPT · Click a bar to see the companies
Why growth scores 83?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its revenue growth and 3-year revenue growth, which are stronger than most Healthcare peers.
- Still loss-making, but the loss per share narrowed. Earnings per share growth: — vs peer median 9.8%
- faster revenue growth over three years: stronger than 78% of peers. 3-year revenue growth: 17.6% vs peer median 5.8%
- faster revenue growth over the last year: stronger than 90% of peers. Revenue growth: 50.1% vs peer median 6.1%
Metric by metric
Position: dot = ADPT, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | ADPT | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 233 reported | 50.1% | 7.7% | 88% | 33% | |
| Earnings per share growthHigher is better · 150 reported | Not reported | 12.0% | — | — | 33% |
| 3-year revenue growthHigher is better · 228 reported | 17.6% | 8.2% | 79% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around ADPT| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 2 | 27.6B SEK (≈$2.8B) | 99 | 76 | |
| 2 | 2.1B USD | 99 | 96 | |
| 2 | 2.8B USD | 99 | 51 | |
| 2 | 15.6B DKK (≈$2.3B) | 99 | 96 | |
| 43 | 3.9B USD | 84 | 47 | |
| 43 | 40.3B SEK (≈$4.0B) | 84 | 79 | |
| 43 | 4.6B USD | 84 | 65 | |
| 47 | 18.3B CNY (≈$2.6B) | 83 | 80 | |
| 47 | 4.1B USD | 83 | 39 | |
| 47 | 3.1B USD | 83 | 53 | |
| 47 | 4.2B USD | 83 | 41 | |
| 51 | 6.2B USD | 82 | 44 | |
| 51 | 6.0B USD | 82 | 30 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score